Niño de 3 meses con anemia hemolítica no autoinmune. Article in Anales de Pediatría 55(3)– · December with 6 Reads. Article in Anales de Pediatría 71(3) · September with 56 Reads Anemia hemolítica autoinmune con prueba de antiglobulina positiva a. de Medicina Interna de una institución pediátrica de alto nivel de complejidad. El paciente consultó por un cuadro de anemia hemolítica autoinmune.
|Genre:||Health and Food|
|Published (Last):||5 June 2006|
|PDF File Size:||7.68 Mb|
|ePub File Size:||18.91 Mb|
|Price:||Free* [*Free Regsitration Required]|
Indian Pediatr, 48pp. Am J Hum Genet ; A review of the current use of rituximab in autoimmune diseases. Glucose—6—phosphate dehydrogenase deficiency in Colombia: Netherlands Language of fulltext: Int Immunopharmacol, 9pp.
The optimal immunosuppresive therapy for aplastic anemia. These therapies are primarily used in patients who are not candidates for or fail to aautoinmune to splenectomy, those who relapse after splenectomy, and those who cannot maintain stable hemoglobin levels without unacceptably high doses of corticosteroids.
Chlorambucil treatment of patients with cold agglutinin syndrome. Acta Med Colomb ; 30 2: Rituximab in pediatric population: Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia. Eur J Intern Med. Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults.
Autoimmune hemolytic anemia with both cold and warm autoinmuen. Treatment of childhood autoimmune hemolytic anemia with rituximab.
Chronic immune thrombocytopenic purpura in children: Barcellini W, Zanella A. Treatment of AIHA, especially in cold antibody-mediated disease, represents a therapeutical challenge.
Corticosteroids, usually prednisone, are given at the initial dose of 1. Additional therapies are intravenous immunoglobulins, danazol, plasma-exchange, and alemtuzumab and high-dose cyclophosphamide as last resort option. However, their aneima is controversial, primarily because only small case series have been reported.
Heterogeneity of G6PD deficiency prevalence in Mozambique: Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome. Targeted B-cell depletion therapy in childhood-onset systemic lupus erythematosus: Rheumatology Oxford44pp. Megadose methylprednisolone for the autoinmkne of patients with Evans syndrome.
J Med Assoc Thai. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: Double blind peer review. Int J Hematol, 84pp. As regards the volume to be transfused, it is worth remembering that overtransfusion should be avoided both for hemodynamic reasons particularly in elderly patientsand for the occurrence of hemoglobinemia and hemoglobinuria, which might not be due to alloantibody-induced hemolysis, as generally thought, but rather to the increase of the total mass of RBCs available for destruction.
Treatment of autoimmune hemolytic anemias
Br J Haematol,pp. No se presentaron eventos adversos. Treatment of autoimmune hemolytic anemia. Prognosis is worse in patients with chronic underlying diseases. Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anemia and auto-immune thrombocytopenic purpura.
The most common indication was lupus nephritis LN Pediatrics Country of publisher: Preventing severe infection after splenectomy. Acosta A, Valverde, K.
Anemia hemolitica 2013 pdf pediatria
Autoimmune haemolysis associated with Donath-Landsteiner antibodies. In less urgent cases, an extended phenotyping is advisable and compatible red cell units may be selected for transfusion. Click on an hour to book an appointment or contact the clinic. Over recent years, some new therapies have become available and there has been some evidence of success. Auttoinmune [ PubMed ].
Treatment of autoimmune hemolytic anemias
February 77 1: Hemoglobin Perth in Costa Rica. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: Successful outcomes with rituximab therapy for refractory childhood systemic lupus erythematosus. Showing 1 – 20 of for search: